NEUROLOGY 2004;62:1882-1884
© 2004 American Academy of Neurology
Brief Communications
L-2-hydroxyglutaric aciduria and brain malignant tumors
A predisposing condition?
I. Moroni, MD,
M. Bugiani, MD,
L. DIncerti, MD,
C. Maccagnano, MD,
M. Rimoldi, PhD,
L. Bissola, PhD,
B. Pollo, MD,
G. Finocchiaro, MD and
G. Uziel, MD
From the Departments of Child Neurology (Drs. Moroni, Bugiani, and Uziel), Neuroradiology (Drs. DIncerti and Maccagnano), Biochemistry and Genetics (Drs. Rimoldi, Bissola, and Finocchiaro), and Neuropathology (Dr. Pollo), National Neurological Institute "C. Besta," Milan, Italy.
Address correspondence and reprint requests to Dr. Graziella Uziel, Dept. of Child Neurology, National Neurologic Institute "C. Besta," Via Celoria 11, 20133 Milan, Italy; e-mail: uziel{at}istituto-besta.it
L-2-hydroxyglutaric aciduria is a rare metabolic encephalopathy displaying a subcortical leukoencephalopathy on MRI. Diagnosis rests on detection of an abnormal accumulation of L-2-hydroxyglutaric acid in body fluids. The authors report on four patients who developed a malignant brain tumor during the course of the disease. This association points to a possible role of L-2-hydroxyglutaric aciduria in predisposing to brain tumorigenesis.
Received September 10, 2003.
Accepted in final form January 8, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
P. Paschka, R. F. Schlenk, V. I. Gaidzik, M. Habdank, J. Kronke, L. Bullinger, D. Spath, S. Kayser, M. Zucknick, K. Gotze, et al.
IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
J. Clin. Oncol.,
August 1, 2010;
28(22):
3636 - 3643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. van den Bent, H. J. Dubbink, Y. Marie, A. A. Brandes, M. J.B. Taphoorn, P. Wesseling, M. Frenay, C. C. Tijssen, D. Lacombe, A. Idbaih, et al.
IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Clin. Cancer Res.,
March 1, 2010;
16(5):
1597 - 1604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Steenweg, G. S. Salomons, Z. Yapici, G. Uziel, E. Scalais, D. I. Zafeiriou, M. L. Ruiz-Falco, V. Mejaski-Bosnjak, P. Augoustides-Savvopoulou, M. Wajner, et al.
L-2-Hydroxyglutaric Aciduria: Pattern of MR Imaging Abnormalities in 56 Patients1
Radiology,
June 1, 2009;
251(3):
856 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lee, M. Born, G. S. Salomons, C. Jakobs, and J. Woelfle
Hemiconvulsion-Hemiplegia-Epilepsy Syndrome as a Presenting Feature of L-2-Hydroxyglutaric Aciduria
J Child Neurol,
June 1, 2006;
21(6):
538 - 540.
[Abstract]
[PDF]
|
 |
|
|